Swiss National Bank’s Karyopharm Therapeutics KPTI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-14,890
| Closed | -$400K | – | 2614 |
|
|
2023
Q2 | $400K | Sell |
14,890
-547
| -4% | -$14.7K | ﹤0.01% | 2573 |
|
|
2023
Q1 | $901K | Sell |
15,437
-1,840
| -11% | -$107K | ﹤0.01% | 2313 |
|
|
2022
Q4 | $881K | Buy |
17,277
+5,980
| +53% | +$305K | ﹤0.01% | 2405 |
|
|
2022
Q3 | $925K | Buy |
11,297
+580
| +5% | +$47.5K | ﹤0.01% | 2379 |
|
|
2022
Q2 | $725K | Hold |
10,717
| – | – | ﹤0.01% | 2512 |
|
|
2022
Q1 | $1.19M | Buy |
10,717
+754
| +8% | +$83.4K | ﹤0.01% | 2325 |
|
|
2021
Q4 | $961K | Buy |
9,963
+1,186
| +14% | +$114K | ﹤0.01% | 2496 |
|
|
2021
Q3 | $766K | Hold |
8,777
| – | – | ﹤0.01% | 2501 |
|
|
2021
Q2 | $1.36M | Buy |
8,777
+927
| +12% | +$144K | ﹤0.01% | 2334 |
|
|
2021
Q1 | $1.24M | Buy |
7,850
+113
| +1% | +$17.8K | ﹤0.01% | 2269 |
|
|
2020
Q4 | $1.8M | Hold |
7,737
| – | – | ﹤0.01% | 1962 |
|
|
2020
Q3 | $1.69M | Buy |
7,737
+907
| +13% | +$199K | ﹤0.01% | 1800 |
|
|
2020
Q2 | $1.94M | Buy |
6,830
+333
| +5% | +$94.6K | ﹤0.01% | 1728 |
|
|
2020
Q1 | $1.87M | Buy |
6,497
+180
| +3% | +$51.9K | ﹤0.01% | 1500 |
|
|
2019
Q4 | $1.82M | Buy |
6,317
+280
| +5% | +$80.5K | ﹤0.01% | 1782 |
|
|
2019
Q3 | $871K | Hold |
6,037
| – | – | ﹤0.01% | 2123 |
|
|
2019
Q2 | $542K | Buy |
6,037
+360
| +6% | +$32.3K | ﹤0.01% | 2394 |
|
|
2019
Q1 | $497K | Hold |
5,677
| – | – | ﹤0.01% | 2372 |
|
|
2018
Q4 | $798K | Hold |
5,677
| – | – | ﹤0.01% | 2131 |
|
|
2018
Q3 | $1.45M | Hold |
5,677
| – | – | ﹤0.01% | 1921 |
|
|
2018
Q2 | $1.45M | Buy |
5,677
+1,400
| +33% | +$357K | ﹤0.01% | 1929 |
|
|
2018
Q1 | $861K | Buy |
4,277
+487
| +13% | +$98K | ﹤0.01% | 2155 |
|
|
2017
Q4 | $546K | Hold |
3,790
| – | – | ﹤0.01% | 2386 |
|
|
2017
Q3 | $624K | Hold |
3,790
| – | – | ﹤0.01% | 2296 |
|
|
2017
Q2 | $514K | Buy |
3,790
+1,067
| +39% | +$145K | ﹤0.01% | 2399 |
|
|
2017
Q1 | $525K | Buy |
2,723
+266
| +11% | +$51.3K | ﹤0.01% | 2363 |
|
|
2016
Q4 | $346K | Hold |
2,457
| – | – | ﹤0.01% | 2492 |
|
|
2016
Q3 | $359K | Hold |
2,457
| – | – | ﹤0.01% | 2441 |
|
|
2016
Q2 | $247K | Buy |
2,457
+167
| +7% | +$16.8K | ﹤0.01% | 2536 |
|
|
2016
Q1 | $296K | Buy |
2,290
+430
| +23% | +$55.6K | ﹤0.01% | 2493 |
|
|
2015
Q4 | $370K | Hold |
1,860
| – | – | ﹤0.01% | 2401 |
|
|
2015
Q3 | $294K | Buy |
1,860
+133
| +8% | +$21K | ﹤0.01% | 2406 |
|
|
2015
Q2 | $705K | Buy |
1,727
+134
| +8% | +$54.7K | ﹤0.01% | 2021 |
|
|
2015
Q1 | $732K | Buy |
1,593
+286
| +22% | +$131K | ﹤0.01% | 1940 |
|
|
2014
Q4 | $734K | Hold |
1,307
| – | – | ﹤0.01% | 1915 |
|
|
2014
Q3 | $685K | Buy |
1,307
+487
| +59% | +$255K | ﹤0.01% | 1895 |
|
|
2014
Q2 | $573K | Buy |
+820
| New | +$573K | ﹤0.01% | 2087 |
|